CompletedPhase 4

Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery

Chile92 participantsStarted 2012-03

Plain-language summary

There some evidence regarding the effect of lidocaine for the prevention of nausea and vomiting in adults.

Who can participate

Age range2 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children between 2 and 12 years * ASA I or II * Programmed for elective tonsillectomy with or without adenoidectomy under general anesthesia Exclusion Criteria: * Obesity, defined as body mass index (BMI) ≥ 95th percentile for age and sex. * Use of antiemetic drugs during the 24 hours before surgery. * Gastroesophageal reflux. * History of allergy to any of the drugs used in the study. * Down Syndrome.

What they're measuring

Evaluating the effectiveness of intravenous lidocaine during anesthesia to decrease the numbers of events (vomiting) during the immediate postoperative period up to 24 hours postoperatively, comparing to placebo

Timeframe: 24 hours

Trial details

NCT IDNCT01986309

SponsorPontificia Universidad Catolica de Chile

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-06

View on ClinicalTrials.gov More Postoperative Nausea and Vomiting trials